{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:24:47Z","timestamp":1792106687725,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["202003N4115"],"award-info":[{"award-number":["202003N4115"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["202003N4118"],"award-info":[{"award-number":["202003N4118"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["2021J080"],"award-info":[{"award-number":["2021J080"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970735"],"award-info":[{"award-number":["81970735"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017553","name":"Zhejiang Key Laboratory of Pathophysiology","doi-asserted-by":"publisher","award":["201908"],"award-info":[{"award-number":["201908"]}],"id":[{"id":"10.13039\/501100017553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.biopha.2022.113684","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:43:56Z","timestamp":1662684236000},"page":"113684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Interleukin-37 ameliorates cigarette smoke-induced lung inflammation in mice"],"prefix":"10.1016","volume":"155","author":[{"given":"Tingting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaobo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2022.113684_bib1","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/erc.10.56","article-title":"Smoking and stroke: the more you smoke the more you stroke","volume":"8","author":"Shah","year":"2010","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2022.113684_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/jnci\/djs136","article-title":"Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975\u20132000","volume":"104","author":"Moolgavkar","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.biopha.2022.113684_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.pupt.2010.04.003","article-title":"COPD and the response of the lung to tobacco smoke exposure","volume":"23","author":"Taylor","year":"2010","journal-title":"Pulm. Pharm. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2022.113684_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12931-018-0927-4","article-title":"MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease","volume":"19","author":"Milara","year":"2018","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.biopha.2022.113684_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2022.113684_bib6","doi-asserted-by":"crossref","first-page":"f3306","DOI":"10.1136\/bmj.f3306","article-title":"Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting beta2 agonist: observational matched cohort study (PATHOS)","volume":"346","author":"Janson","year":"2013","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.biopha.2022.113684_bib7","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","article-title":"Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD","volume":"374","author":"Wedzicha","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.biopha.2022.113684_bib8","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1074\/jbc.275.14.10308","article-title":"Identification and initial characterization of four novel members of the interleukin-1 family","volume":"275","author":"Kumar","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2022.113684_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113684_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/imr.12605","article-title":"Suppression of inflammation and acquired immunity by IL-37","volume":"281","author":"Cavalli","year":"2018","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2022.113684_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095346","article-title":"Plasma levels of IL-37 and correlation with TNF-alpha, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113684_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1479-5876-12-69","article-title":"IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity","volume":"12","author":"Ye","year":"2014","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.113684_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10875-012-9791-z","article-title":"Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus","volume":"33","author":"Song","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113684_bib14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/cei.12608","article-title":"Interleukin-1 family cytokines and their regulatory proteins in normal pregnancy and pre-eclampsia","volume":"181","author":"Southcombe","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2022.113684_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/639712","article-title":"Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barre syndrome","volume":"2013","author":"Li","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2022.113684_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12967-015-0394-3","article-title":"Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity","volume":"13","author":"Chen","year":"2015","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.biopha.2022.113684_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107183","article-title":"Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2022.113684_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/cei.12061","article-title":"Epithelial expression of interleukin-37b in inflammatory bowel disease","volume":"172","author":"Imaeda","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113684_bib19","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/MPG.0000000000000387","article-title":"Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease","volume":"59","author":"Weidlich","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"10","key":"10.1016\/j.biopha.2022.113684_bib20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1089\/jir.2013.0001","article-title":"Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment","volume":"33","author":"Li","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.biopha.2022.113684_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2119\/molmed.2015.00031","article-title":"Interleukin-37 expression is increased in chronic HIV-1-infected individuals and is associated with inflammation and the size of the total viral reservoir","volume":"21","author":"Hojen","year":"2015","journal-title":"Mol. Med."},{"issue":"11","key":"10.1016\/j.biopha.2022.113684_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004462","article-title":"IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis","volume":"10","author":"Moretti","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2022.113684_bib23","first-page":"762","article-title":"Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37","volume":"5","author":"van de Veerdonk","year":"2014","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113684_bib24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1440-1746.2012.07187.x","article-title":"Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells","volume":"27","author":"Sakai","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113684_bib25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/cei.12284","article-title":"Interleukin-37 ameliorates myocardial ischaemia\/reperfusion injury in mice","volume":"176","author":"Wu","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113684_bib26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.2014.295","article-title":"IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury","volume":"87","author":"Yang","year":"2015","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.biopha.2022.113684_bib27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1089\/jir.2014.0212","article-title":"The protective effect of interleukin-37 on vascular calcification and atherosclerosis in apolipoprotein E-deficient mice with diabetes","volume":"35","author":"Chai","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.113684_bib28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1159\/000487344","article-title":"Transgenic overexpression of IL-37 protects against atherosclerosis and strengthens plaque stability","volume":"45","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2022.113684_bib29","first-page":"5247","article-title":"Effects of interleukin-37 on cardiac function after myocardial infarction in mice","volume":"8","author":"Xu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113684_bib30","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.autrev.2015.08.006","article-title":"Insights into IL-37, the role in autoimmune diseases","volume":"14","author":"Xu","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"26","key":"10.1016\/j.biopha.2022.113684_bib31","doi-asserted-by":"crossref","first-page":"21775","DOI":"10.18632\/oncotarget.4887","article-title":"IL-37 restrains autoimmune diseases","volume":"6","author":"Ye","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.biopha.2022.113684_bib32","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.3390\/ijms19082264","article-title":"IL-37 expression reduces lean body mass in mice by reducing food intake","volume":"19","author":"Kuipers","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113684_bib33","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1038\/ncomms5711","article-title":"IL-37 protects against obesity-induced inflammation and insulin resistance","volume":"5","author":"Ballak","year":"2014","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2022.113684_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/imm.12020","article-title":"Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice","volume":"138","author":"Qiu","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2022.113684_bib35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.biopha.2018.12.028","article-title":"Interleukin-35 expression protects against cigarette smoke-induced lung inflammation in mice","volume":"110","author":"Pan","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.biopha.2022.113684_bib36","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s10753-018-0820-9","article-title":"Interleukin-37 attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice","volume":"41","author":"Li","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2022.113684_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.intimp.2015.11.015","article-title":"Lentivirus expressing soluble ST2 alleviates bleomycin-induced pulmonary fibrosis in mice","volume":"30","author":"Gao","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113684_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbrc.2014.04.010","article-title":"Hydrodynamic delivery of IL-28B (IFN-lambda3) gene ameliorates lung inflammation induced by cigarette smoke exposure in mice","volume":"447","author":"Qiu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2022.113684_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000107058","article-title":"Animal models of cigarette smoke-induced chronic obstructive lung disease","volume":"14","author":"Churg","year":"2007","journal-title":"Contrib. Microbiol."},{"key":"10.1016\/j.biopha.2022.113684_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12971-017-0130-2","article-title":"Experimental animal models for COPD: a methodological review","volume":"15","author":"Ghorani","year":"2017","journal-title":"Tob. Induc. Dis."},{"key":"10.1016\/j.biopha.2022.113684_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.intimp.2017.03.009","article-title":"Platycodin D protects against cigarette smoke-induced lung inflammation in mice","volume":"47","author":"Gao","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113684_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1165\/rcmb.2017-0200TR","article-title":"Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: role of cigarette smoke exposure","volume":"58","author":"Aghapour","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113684_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2174\/156801005774912824","article-title":"Inflammatory cells and chronic obstructive pulmonary disease","volume":"4","author":"Tetley","year":"2005","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"issue":"2","key":"10.1016\/j.biopha.2022.113684_bib44","first-page":"86","article-title":"Association of severity of COPD with IgE and interleukin-1 beta","volume":"73","author":"Singh","year":"2010","journal-title":"Monaldi Arch. Chest Dis."},{"key":"10.1016\/j.biopha.2022.113684_bib45","first-page":"995","article-title":"Novel aspects of pathogenesis and regeneration mechanisms in COPD","volume":"10","author":"Bagdonas","year":"2015","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2022.113684_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2022.113684_bib47","doi-asserted-by":"crossref","first-page":"L122","DOI":"10.1152\/ajplung.00301.2016","article-title":"Role of IL-17A in murine models of COPD airway disease","volume":"312","author":"Yanagisawa","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.biopha.2022.113684_bib48","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2147\/COPD.S159915","article-title":"Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema","volume":"13","author":"Di Stefano","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2022.113684_bib49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1521-4141(200202)32:2<393::AID-IMMU393>3.0.CO;2-5","article-title":"Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis","volume":"32","author":"Drost","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113684_bib50","first-page":"2198","article-title":"Recombinant club cell protein 16 (CC16) ameliorates cigarette smokeinduced lung inflammation in a murine disease model of COPD","volume":"18","author":"Pang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2022.113684_bib51","first-page":"1758","article-title":"IL-33 induced inflammation exacerbated the development of chronic obstructive pulmonary disease through oxidative stress","volume":"22","author":"Zou","year":"2018","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113684_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1189\/jlb.0712349","article-title":"Myeloperoxidase: a front-line defender against phagocytosed microorganisms","volume":"93","author":"Klebanoff","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2022.113684_bib53","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2147\/COPD.S113484","article-title":"Characterization of sputum biomarkers for asthma-COPD overlap syndrome","volume":"11","author":"Gao","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2022.113684_bib54","first-page":"1215","article-title":"Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap","volume":"38","author":"Yang","year":"2018","journal-title":"Nan Fang. Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.biopha.2022.113684_bib55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.rmed.2015.10.009","article-title":"Effects of doxycycline on local and systemic inflammation in stable COPD patients, a randomized clinical trial","volume":"110","author":"Prins","year":"2016","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.biopha.2022.113684_bib56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/imcb.12223","article-title":"IL-37 alleviates house dust mite-induced chronic allergic asthma by targeting TSLP through the NF-kappaB and ERK1\/2 signaling pathways","volume":"97","author":"Meng","year":"2019","journal-title":"Immunol. Cell Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:28:14Z","timestamp":1781782094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222010733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":56,"alternative-id":["S0753332222010733"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113684","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-37 ameliorates cigarette smoke-induced lung inflammation in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113684"}}